Fibroblast Activation Protein Promotes Thoracic Aortic Dissection via PLAUR/ITGB1‐Mediated Pro‐inflammatory Macrophage Polarization
Advanced Science · 2026
DOI: 10.1002/advs.202514786 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Hongqiao Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Macrophages, Membrane Proteins, Gelatinases, Integrin beta1. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Qingdao Municipal Bureau of Science and Technology, Natural Science Foundation of Qingdao Municipality.
Abstract (Originalsprache)
Background
Thoracic aortic dissection (TAD) is a lethal vascular emergency lacking targeted therapies. Fibroblast activation protein (FAP), a protease implicated in tissue remodeling, exhibits unknown roles in TAD pathogenesis.
Methods
Human TAD specimens and β‐aminopropionitrile‐induced TAD models were used to assess FAP expression. Global and fibroblast‐specific Fap knockout mice were generated to evaluate biological effects of FAP. Bulk and single‐cell RNA sequencing were used to map cellular crosstalk and dysregulated signaling pathways. A combination of pharmacological inhibition (Ac‐Gly‐BoroPro), surface plasmon resonance (SPR), co‐immunoprecipitation (co‐IP), and functional rescue experiments was utilized to dissect the enzymatic versus nonenzymatic functions of FAP and its interaction with PLAUR/ITGB1 signaling.
Results
Fibroblast‐derived FAP was significantly upregulated in TAD lesions. Fap deletion markedly attenuated inflammatory infiltration, extracellular matrix degradation, and TAD incidence. Surprisingly, pharmacological inhibition of FAP's enzymatic activity failed to protect against TAD. SPR, co‐IP, and functional assays revealed that FAP binds directly to macrophage PLAUR via nonenzymatic sites. This interaction triggers ITGB1/FAK signaling, promoting a pro‐inflammatory macrophage phenotype that drives TAD progression.
Conclusion
This study demonstrates that FAP promotes TAD through a nonenzymatic mechanism involving fibroblast‐macrophage crosstalk via the FAP/PLAUR/ITGB1/FAK axis. Targeting this pathway might offer a promising therapeutic strategy for TAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Nursing, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Vascular Surgery, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
- Department of Vascular Surgery, The First Affiliated Hospital, Naval Medical University, Shanghai, China.
ORCID-Profile: Junjun Liu
Förderung
- National Natural Science Foundation of China
- Qingdao Municipal Bureau of Science and Technology
- Natural Science Foundation of Qingdao Municipality
Zitieren
APA
Zhu, H., Wu, J., Xu, Z., Pei, Y., Jing, Z., Zhou, J., Feng, R., & Liu, J. (2026). Fibroblast Activation Protein Promotes Thoracic Aortic Dissection via PLAUR/ITGB1‐Mediated Pro‐inflammatory Macrophage Polarization. Advanced Science. https://doi.org/10.1002/advs.202514786
Vancouver
Zhu H, Wu J, Xu Z, Pei Y, Jing Z, Zhou J, et al. Fibroblast Activation Protein Promotes Thoracic Aortic Dissection via PLAUR/ITGB1‐Mediated Pro‐inflammatory Macrophage Polarization. Advanced Science. 2026. doi:10.1002/advs.202514786
BibTeX
@article{Zhu2026,
author = {Zhu, Hongqiao and Wu, Jianlie and Xu, Ziyi and Pei, Yifei and Jing, Zaiping and Zhou, Jian and Feng, Rui and Liu, Junjun},
title = {Fibroblast Activation Protein Promotes Thoracic Aortic Dissection via PLAUR/ITGB1‐Mediated Pro‐inflammatory Macrophage Polarization},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202514786}
}
EUVIMED